14.1 C
Tuesday, March 21, 2023

Deep Learning Model May Help Expand Lung Screening Programs

The deep learning model, known as Sybil, predicts future lung cancer risk based on a single low-dose chest CT and can identify individuals who would benefit from regular monitoring. Medscape Medical News

Could Your Patients Benefit? New Trials in Lung Cancer

Several studies in lung cancer have started enrolling recently – maybe one of your patients could benefit. Medscape Medical News

Less Invasive NSCLC Surgery Does Not Compromise Survival

A US trial showing that sublobar resection achieves similar survival outcomes as lobar resection could usher in precision lung cancer surgery, says expert. Medscape Medical News

Lung Cancer Risk Rises With A1c, Falls With Medication

Prospective data from about 283,000 cancer-free people in a large database showed a significant positive link between incident lung cancer and A1c in people with diabetes or prediabetes. First Look

Medical Practice Gave 8000 Patients Cancer for Christmas

Instead of expressing a simple expression of joy for the holiday season, one clinic in the UK accidentally informed all 8000 of its patients that that they had aggressive lung cancer with metastases. MDedge News

Atezolizumab Plus Bevacizumab: A New Standard for Some NSCLC?

Encouraging findings with the combination suggest that it could offer a new standard treatment for patients with highly mutated non–small cell lung cancer. Medscape Medical News

Adagrasib (Krazati) Approved for KRAS-Mutated NSCLC

It becomes the second KRAS-targeted therapy for use in patients with non–small cell lung cancer (NSCLC) whose tumors have this mutation. FDA Approvals

Racial Disparities in Lung Cancer Start With Research

Improving lung cancer outcomes in Black communities will take more than lowering the screening age, experts say. Kaiser Health News

FDA Rejects Piziotinib for Certain Types of NSCLC

The drug was not approved for the treatment of patients with previously treated locally advanced or metastatic nonsmall cell lung cancer harboring HER2 exon 20 insertion mutations. Medscape Medical News

Over Half of Targetable NSCLC Patients Miss Out on Correct Tx

Most patients with advanced non–small cell lung cancer (NSCLC) have tumors with actionable mutations, but two thirds of them are not receiving targeted therapy owing to gaps in clinical practice. Medscape Medical News

Time Management Tips


few clouds
14.1 ° C
15.4 °
10.6 °
73 %
20 %
14 °
18 °
18 °
17 °
19 °

Must Read